News Center - Life Science Research Articles & Updates

News Center
  • 14
    2026.07
    🐂 Swine, Cattle, Poultry & Aquaculture 🧬 DNA + RNA Co-Extraction 🧪 Virus + Bacteria + Fungi 🤖 Automation-Ready Livestock Pathogen Detection Starts Here: High-Efficiency Nucleic Acid Extraction from Swabs, Blood, Feces & Tissue From swine nasal swabs and cattle blood clots to poultry cloacal swabs, tissue organs, and fecal samples — the YALEPIC® MagEVO magnetic bead-based DNA/RNA co-extraction kit delivers one-tube, multi-species pathogen purification for modern veterinary molecular diagnostics. 6 Sample Types Covered A260/A280 1.8–2.0 High Purity Inhibitor-Free +30% Trace Pathogen Detection Rate 96 Samples/Batch Automation 12 Months Room Temp Storage 🦬 Common Livestock Pathogens by Species Pathogens in livestock operations span viruses, bacteria, and fungi. Each species faces a distinct pathogen spectrum, and mixed infections are the rule rather than the exception — PRRSV frequently co-occurs with Haemophilus parasuis or Streptococcus suis in swine; avian influenza is often complicated by secondary E. coli infection. 🧠 Viruses (DNA & RNA) 🐖 Swine ASFV, PRRSV, CSFV, PCV2/3, PEDV, TGEV 🐓 Poultry AIV, NDV, IBDV, IBV 🐂 Cattle & Sheep FMDV, LSDV, BVDV 🧫 Bacteria (G+ & G−) 🐖 Swine Streptococcus suis, Actinobacillus pleuropneumoniae, Haemophilus parasuis, E. coli 🐓 Poultry Salmonella Pullorum, Pasteurella, Riemerella anatipestifer 🐂 Cattle & Sheep Mycobacterium bovis,…
    View more
  • 14
    2026.07
    🌍 Soil & Stool 🧪 Column + Magnetic Bead ⚙️ Patented Inhibitor Removal 🤖 Pure 32 Auto Soil & Stool Nucleic Acid Extraction: Conquering Complex Samples for Microbiome Research From patented inhibitor removal to dual-platform extraction and fully automated workflows — YALI BIOTECH delivers the complete solution for soil and stool microbiome nucleic acid extraction, trusted by leading agricultural institutes and clinical research centers. Preservation → Pre-Treatment → Column/Magnetic Bead Extraction → Pure 32 Automation • A260/A230 > 1.9 • 16S PCR Success > 98% A260/A230 > 1.9 Superior Inhibitor Removal > 98% 16S PCR Success Rate +25% More OTUs vs. Traditional Methods CV < 3% Pure 32 Inter-Well Precision RIN > 7.0 RNA Integrity Metatranscriptomics-Ready 🌍 The Strategic Value of Microbiome Research Microbiomics — the study of entire microbial genomes and their functions within an environment — is rapidly advancing from basic research into clinical translation and industrial application. From soil microbial ecology to the human gut microbiome, from environmental monitoring to disease diagnosis, microbiome research is reshaping multiple scientific disciplines. 🌱 Soil Microbiome 109–1010 cells per gram Each gram of soil hosts 109–1010 microbial cells — the most complex microbial habitat on Earth. Soil microbes drive carbon and…
    View more
  • 14
    2026.07
    🧬 DNA/RNA Co-Extraction 🧫 Virus + Bacteria + Fungus 🤖 Automation Ready 📦 RT Storage From Sample to Result: Pathogen Nucleic Acid Extraction in Clinical Diagnostics Master pathogen DNA/RNA co-extraction with YALEPIC® MagEVO magnetic bead kits — simultaneous viral, bacterial, and fungal nucleic acid isolation from whole blood, swabs, sputum, BALF, CSF, stool, and more. Cat# YG28001 • 96 tests • Pre-filled plate options available • 10–30 °C room-temperature storage • 18-month shelf life >85% Recovery Rate Hard-to-Lyse Pathogens A260/A280 Stable 1.8–2.0 Ultra-High Purity CV <5% Batch Consistency 10-Run Validation 96 Samples Per Batch High-Throughput 18 Months Shelf Life Room Temperature 🧬 Why “One Kit for All Pathogens” Is So Challenging Pathogenic microorganisms span viruses, bacteria, and fungi — each with distinct nucleic acid types (DNA or RNA), cellular structures, and lysis resistance. In real-world clinical settings, co-infections are common: a single patient may carry both bacterial and viral pathogens simultaneously. An extraction kit must offer broad-spectrum compatibility to avoid missed detections. 🧠 Viruses (DNA / RNA) Influenza A/B, SARS-CoV-2, Adenovirus, HBV, CMV, EBV — nucleic acid can be DNA or RNA, requiring simultaneous co-extraction. Single-stranded & Double-stranded 🧫 Bacteria (G+ / G−) Staphylococcus, Streptococcus pneumoniae, E. coli, Salmonella, Shigella,…
    View more
  • 14
    2026.07
    FOOD SAFETY • MOLECULAR TESTING Magnetic Bead-Based Nucleic Acid Extraction for Food Safety: Faster, Smarter, Fully Traceable Powered by YALEPIC® magnetic bead technology and fully automated extraction instruments, our purpose-built food safety testing solutions deliver high-purity DNA/RNA from complex food matrices — enabling rapid adulteration detection, pathogen screening, GMO identification, and food traceability, fully aligned with the new GB/T 27403-2026 laboratory quality control standard. 🧪 Nucleic Acid Extraction 🌱 GMO Testing 🦠 Pathogen Screening 🔎 Adulteration Detection GB/T 27403-2026: The New Benchmark for Food Molecular Testing Labs In March 2026, GB/T 27403-2026 "Laboratory Quality Control Specification — Food Molecular Biology Testing" officially took effect, replacing the 2008 version. Co-drafted by the China Customs Science and Technology Research Center, China National Accreditation Center for Conformity Assessment, and Inner Mongolia Yili Industrial Group, this new standard establishes a comprehensive quality control framework spanning general, structural, resource, process, and management system requirements. For food testing laboratories — whether in-house corporate labs or third-party facilities — this marks a mandatory upgrade from equipment to workflow. ⚙ General Impartiality, confidentiality, management framework ★ Structural Organization, roles, personnel competency ⚛ Resources Instruments, reagents, environmental facilities ⏱ Process Sample prep, extraction, full testing workflow ✎ Management Document…
    View more
  • 14
    2026.07
    LIQUID BIOPSY • cfDNA EXTRACTION cfDNA Extraction Kits: The Critical Pre-Analytical Foundation for Cancer Liquid Biopsy YALEPIC® magnetic bead-based cfDNA extraction kits deliver high-recovery, high-purity isolation of 150–170 bp short fragments from plasma, serum, and urine — providing a rock-solid pre-analytical foundation for cancer early screening, ctDNA mutation detection, NGS library preparation, and MRD monitoring. 🔬 Liquid Biopsy 🧪 cfDNA Extraction 🔎 Cancer Screening 🎯 ctDNA Detection Why cfDNA Extraction Is the First Critical Checkpoint in Cancer Liquid Biopsy In the era of precision medicine, liquid biopsy has emerged as a transformative approach for non-invasive cancer screening, therapy monitoring, and recurrence surveillance. Unlike traditional tissue biopsy requiring invasive needle biopsy or surgical sampling, liquid biopsy only needs a peripheral blood draw or body fluid collection to capture circulating tumor DNA (ctDNA) — enabling earlier tumor signal detection with minimal patient burden. ctDNA is just a small subset of total cfDNA (cell-free DNA). In healthy individuals, cfDNA concentration in peripheral blood is about 10–1,000 copies/mL. In early-stage cancer patients, ctDNA may account for as little as 0.01%–1% of total cfDNA. This means cfDNA extraction recovery and purity directly determine the lower limit of ctDNA detection sensitivity. Inefficient extraction causes short-fragment loss…
    View more
+86-512-66256010